UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION
                             Washington, D.C. 20549


                                 SCHEDULE 13D/A


                    Under the Securities Exchange Act of 1934
                               (Amendment No.  2  )*
                                             -----

                                  AMEDISYS, INC.
--------------------------------------------------------------------------------
                                (Name of Issuer)


                                     COMMON
--------------------------------------------------------------------------------
                         (Title of Class of Securities)


                                    023436108
                         ------------------------------
                                 (CUSIP Number)

     David Nierenberg, The D3 Family Fund, 19605 NE 8th St., Camas, WA  98607
                                  (360)604-8600
 ------------------------------------------------------------------------------
                      (Name, Address and Telephone Number
                        of Person Authorized to Receive
                          Notices and Communications)


                                    10/22/02
                        -------------------------------
                         (Date of Event which Requires
                           Filing of this Statement)



*The remainder of this cover page shall be filled out for a reporting
person's initial filing on this form with respect to the subject class of
securities, and for any subsequent amendment containing information which
would alter the disclosures provided in a prior cover page.

The information required in the remainder of this cover page shall not be
deemed to be "filed" for the purpose of Section 18 of the Securities
Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of
that section of the Act but shall be subject to all other provisions of the
Act (however, see the Notes).

                                                                         1 of 17

                                  SCHEDULE 13D

CUSIP No. 023436108                                                 Page 2 of 17

 1)   NAME OF REPORTING PERSON
      S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON

      The D3 Family Fund, L.P. (David Nierenberg is President of the General
      Partner, which is Nierenberg Investment Management Company, Inc.)
      --------------------------------------------------------------------------

 2)   CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*
                                                                 (a)   [ X ]
                                                                 (b)   [   ]
      --------------------------------------------------------------------------

 3)   SEC USE ONLY

      --------------------------------------------------------------------------

 4)   SOURCE OF FUNDS

      WC
      --------------------------------------------------------------------------

 5)   CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED
      PURSUANT TO ITEMS 2(d) or 2(e)                                   [   ]

      --------------------------------------------------------------------------
 6)   CITIZENSHIP OR PLACE OF ORGANIZATION

      Washington
      --------------------------------------------------------------------------

                          7)  SOLE VOTING POWER
      NUMBER OF
                              912,000 (10.1%)
      SHARES                  --------------------------------------------------

      BENEFICIALLY        8)  SHARED VOTING POWER

      OWNED BY                0
                              --------------------------------------------------
      EACH
                          9)  SOLE DISPOSITIVE POWER
      REPORTING
                              912,000
      PERSON                  --------------------------------------------------

      WITH               10)  SHARED DISPOSITIVE POWER

                              0
                              --------------------------------------------------

11)   AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

      Aggregate amount owned is 979,000 shares (10.8%)

      --------------------------------------------------------------------------

12)   CHECK IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN
      SHARES*                                                          [   ]

      --------------------------------------------------------------------------

13)   PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)

      10.8%
      --------------------------------------------------------------------------

14)   TYPE OF REPORTING PERSON*

      PN
      --------------------------------------------------------------------------

                                  SCHEDULE 13D

CUSIP No. 023436108                                                 Page 3 of 17

 1)   NAME OF REPORTING PERSON
      S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON

      Haredale, Ltd.
      --------------------------------------------------------------------------

 2)   CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*
                                                                 (a)   [ X ]
                                                                 (b)   [   ]
      --------------------------------------------------------------------------
 3)   SEC USE ONLY

      --------------------------------------------------------------------------
 4)   SOURCE OF FUNDS

      WC
      --------------------------------------------------------------------------

 5)   CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED
      PURSUANT TO ITEMS 2(d) or 2(e)                                   [   ]
      --------------------------------------------------------------------------

 6)   CITIZENSHIP OR PLACE OF ORGANIZATION

      The Bahamas
      --------------------------------------------------------------------------

                          7)  SOLE VOTING POWER
      NUMBER OF
                              24,500 (0.3%)
      SHARES                  --------------------------------------------------

      BENEFICIALLY        8)  SHARED VOTING POWER

      OWNED BY                0
                              --------------------------------------------------
      EACH
                          9)  SOLE DISPOSITIVE POWER
      REPORTING
                              24,500
      PERSON                  --------------------------------------------------

      WITH               10)  SHARED DISPOSITIVE POWER

                              0
                              --------------------------------------------------

11)   AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

      Aggregate amount owned is 979,000 shares (10.8%)
      --------------------------------------------------------------------------

12)   CHECK IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN
      SHARES*                                                          [   ]


      --------------------------------------------------------------------------

13)   PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)

      10.8%
      --------------------------------------------------------------------------

14)   TYPE OF REPORTING PERSON*

      CO
      --------------------------------------------------------------------------

                                   SCHEDULE 13D

CUSIP No. 023436108                                                 Page 4 of 17

 1)   NAME OF REPORTING PERSON
      S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON

      Olivier Roux
      --------------------------------------------------------------------------

 2)   CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*
                                                                 (a)   [ X ]
                                                                 (b)   [   ]
      --------------------------------------------------------------------------
 3)   SEC USE ONLY

      --------------------------------------------------------------------------
 4)   SOURCE OF FUNDS

      WC
      --------------------------------------------------------------------------

 5)   CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED
      PURSUANT TO ITEMS 2(d) or 2(e)                                   [   ]

      --------------------------------------------------------------------------
 6)   CITIZENSHIP OR PLACE OF ORGANIZATION

      French citizen resident in United Kingdom
      --------------------------------------------------------------------------

                          7)  SOLE VOTING POWER
      NUMBER OF
                              10,000 (0.1%)
      SHARES                  --------------------------------------------------

      BENEFICIALLY        8)  SHARED VOTING POWER

      OWNED BY                0
                              --------------------------------------------------
      EACH
                          9)  SOLE DISPOSITIVE POWER
      REPORTING
                              10,000
      PERSON                  --------------------------------------------------

      WITH               10)  SHARED DISPOSITIVE POWER

                              0
                              --------------------------------------------------

11)   AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

      Aggregate amount owned is 979,000 shares (10.8%)
      --------------------------------------------------------------------------

12)   CHECK IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN
      SHARES*                                                          [   ]


      --------------------------------------------------------------------------

13)   PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)

      10.8%
      --------------------------------------------------------------------------

14)   TYPE OF REPORTING PERSON*

      IN
      --------------------------------------------------------------------------

                                  SCHEDULE 13D

CUSIP No. 023436108                                                 Page 5 of 17

 1)   NAME OF REPORTING PERSON
      S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON

      James Henry Hildebrandt
      --------------------------------------------------------------------------

 2)   CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*
                                                                 (a)   [ X ]
                                                                 (b)   [   ]
      --------------------------------------------------------------------------
 3)   SEC USE ONLY

      --------------------------------------------------------------------------
 4)   SOURCE OF FUNDS

      WC
      --------------------------------------------------------------------------

 5)   CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED
      PURSUANT TO ITEMS 2(d) or 2(e)                                   [   ]

      --------------------------------------------------------------------------
 6)   CITIZENSHIP OR PLACE OF ORGANIZATION

      Canadian citizen resident in Hong Kong
      --------------------------------------------------------------------------

                          7)  SOLE VOTING POWER
      NUMBER OF
                              7,000 (0.1%)
      SHARES                  --------------------------------------------------

      BENEFICIALLY        8)  SHARED VOTING POWER

      OWNED BY                0
                              --------------------------------------------------
      EACH
                          9)  SOLE DISPOSITIVE POWER
      REPORTING
                              7,000
      PERSON                  --------------------------------------------------

      WITH               10)  SHARED DISPOSITIVE POWER

                              0
                              --------------------------------------------------

11)   AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

      Aggregate amount owned is 979,000 shares (10.8%)
      --------------------------------------------------------------------------

12)   CHECK IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN
      SHARES*                                                          [   ]


      --------------------------------------------------------------------------

13)   PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)

      10.8%
      --------------------------------------------------------------------------

14)   TYPE OF REPORTING PERSON*

      IN
      --------------------------------------------------------------------------

                                  SCHEDULE 13D

CUSIP No. 023436108                                                 Page 6 of 17

 1)   NAME OF REPORTING PERSON
      S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON

      Toxford Corporation
      --------------------------------------------------------------------------

 2)   CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*
                                                                 (a)   [ X ]
                                                                 (b)   [   ]
      --------------------------------------------------------------------------
 3)   SEC USE ONLY

      --------------------------------------------------------------------------
 4)   SOURCE OF FUNDS

      WC
      --------------------------------------------------------------------------

 5)   CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED
      PURSUANT TO ITEMS 2(d) or 2(e)                                   [   ]

      --------------------------------------------------------------------------
 6)   CITIZENSHIP OR PLACE OF ORGANIZATION

      Channel Islands, British Isles
      --------------------------------------------------------------------------

                          7)  SOLE VOTING POWER
      NUMBER OF
                              4,000 (0.0%)
      SHARES                  --------------------------------------------------

      BENEFICIALLY        8)  SHARED VOTING POWER

      OWNED BY                0
                              --------------------------------------------------
      EACH
                          9)  SOLE DISPOSITIVE POWER
      REPORTING
                              4,000
      PERSON                  --------------------------------------------------

      WITH               10)  SHARED DISPOSITIVE POWER

                              0
                              --------------------------------------------------

11)   AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

      Aggregate amount owned is 979,000 shares (10.8%)
      --------------------------------------------------------------------------

12)   CHECK IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN
      SHARES*                                                          [   ]


      --------------------------------------------------------------------------

13)   PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)

      10.8%
      --------------------------------------------------------------------------

14)   TYPE OF REPORTING PERSON*

      CO
      --------------------------------------------------------------------------

                                   SCHEDULE 13D

CUSIP No. 023436108                                                 Page 7 of 17

 1)   NAME OF REPORTING PERSON
      S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON

      Henry E. Hooper
      --------------------------------------------------------------------------

 2)   CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*
                                                                 (a)   [ X ]
                                                                 (b)   [   ]
      --------------------------------------------------------------------------
 3)   SEC USE ONLY

      --------------------------------------------------------------------------
 4)   SOURCE OF FUNDS

      WC
      --------------------------------------------------------------------------

 5)   CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED
      PURSUANT TO ITEMS 2(d) or 2(e)                                   [   ]

      --------------------------------------------------------------------------
 6)   CITIZENSHIP OR PLACE OF ORGANIZATION

      Washington
      --------------------------------------------------------------------------

                          7)  SOLE VOTING POWER
      NUMBER OF
                              1,500 (0.0%)
      SHARES                  --------------------------------------------------

      BENEFICIALLY        8)  SHARED VOTING POWER

      OWNED BY                0
                              --------------------------------------------------
      EACH
                          9)  SOLE DISPOSITIVE POWER
      REPORTING
                              1,500
      PERSON                  --------------------------------------------------

      WITH               10)  SHARED DISPOSITIVE POWER

                              0
                              --------------------------------------------------

11)   AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

      Aggregate amount owned is 979,000 shares (10.8%)
      --------------------------------------------------------------------------

12)   CHECK IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN
      SHARES*                                                          [   ]


      --------------------------------------------------------------------------

13)   PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)

      10.8%
      --------------------------------------------------------------------------

14)   TYPE OF REPORTING PERSON*

      IN
      --------------------------------------------------------------------------

                                   SCHEDULE 13D

CUSIP No. 023436108                                                 Page 8 of 17

 1)   NAME OF REPORTING PERSON
      S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON

      Florence Cies
      --------------------------------------------------------------------------

 2)   CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*
                                                                 (a)   [ X ]
                                                                 (b)   [   ]
      --------------------------------------------------------------------------
 3)   SEC USE ONLY

      --------------------------------------------------------------------------
 4)   SOURCE OF FUNDS

      WC
      --------------------------------------------------------------------------

 5)   CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED
      PURSUANT TO ITEMS 2(d) or 2(e)                                   [   ]

      --------------------------------------------------------------------------
 6)   CITIZENSHIP OR PLACE OF ORGANIZATION

      California
      --------------------------------------------------------------------------

                          7)  SOLE VOTING POWER
      NUMBER OF
                              10,000 (0.1%)
      SHARES                  --------------------------------------------------

      BENEFICIALLY        8)  SHARED VOTING POWER

      OWNED BY                0
                              --------------------------------------------------
      EACH
                          9)  SOLE DISPOSITIVE POWER
      REPORTING
                              10,000
      PERSON                  --------------------------------------------------

      WITH               10)  SHARED DISPOSITIVE POWER

                              0
                              --------------------------------------------------

11)   AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

      Aggregate amount owned is 979,000 shares (10.8%)
      --------------------------------------------------------------------------

12)   CHECK IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN
      SHARES*                                                          [   ]


      --------------------------------------------------------------------------

13)   PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)

      10.8%
      --------------------------------------------------------------------------

14)   TYPE OF REPORTING PERSON*

      IN
      --------------------------------------------------------------------------

                                  SCHEDULE 13D

CUSIP No. 023436108                                                Page 9 of 17

 1)   NAME OF REPORTING PERSON
      S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON

      The David and Patricia Nierenberg 1993 Irrevocable Trust,
      Lawrence K. Orr, Trustee, June 11, 1993
      --------------------------------------------------------------------------

 2)   CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*
                                                                 (a)   [ X ]
                                                                 (b)   [   ]
      --------------------------------------------------------------------------
 3)   SEC USE ONLY

      --------------------------------------------------------------------------
 4)   SOURCE OF FUNDS

      WC
      --------------------------------------------------------------------------

 5)   CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED
      PURSUANT TO ITEMS 2(d) or 2(e)                                   [   ]

      --------------------------------------------------------------------------
 6)   CITIZENSHIP OR PLACE OF ORGANIZATION

      Washington
      --------------------------------------------------------------------------

                          7)  SOLE VOTING POWER
      NUMBER OF
                              10,000 (0.1%)
      SHARES                  --------------------------------------------------

      BENEFICIALLY        8)  SHARED VOTING POWER

      OWNED BY                0
                              --------------------------------------------------
      EACH
                          9)  SOLE DISPOSITIVE POWER
      REPORTING
                              10,000
      PERSON                  --------------------------------------------------

      WITH               10)  SHARED DISPOSITIVE POWER

                              0
                              --------------------------------------------------

11)   AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

      Aggregate amount owned is 979,000 shares (10.8%)
      --------------------------------------------------------------------------

12)   CHECK IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN
      SHARES*                                                          [   ]


      --------------------------------------------------------------------------

13)   PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)

      10.8%
      --------------------------------------------------------------------------

14)   TYPE OF REPORTING PERSON*

      OO  (Irrevocable trust)
      --------------------------------------------------------------------------

                                                                  Page 10 of 17

Item 1.  Security and Issuer

         Common stock of Amedisys, Inc. (AMED),
         11100 Mead Road, Suite 300,
         Baton Rouge, LA 70816

Item 2.  Identity and Background

         The D3 Family Fund, L.P., a Washington State limited partnership, whose
         principal business is investing in domestic micro-cap public equities.
         Located at 19605 N.E. 8th St., Camas, Washington 98607. No convictions
         or administrative proceedings as described in Item 2(d) and (e).

Item 3.  Source and Amount of Funds or Other Consideration

         Source of funds is money invested in the partnership by its partners.
         Aggregate amount invested by D3 in AMED is $6,437,700.

Item 4.  Purpose of Transaction

         We have modified the objective of our investment in Amedisys from
         passive investment to a more active role in helping the company build
         the capabilities and resources required to exploit fully the market
         opportunities available to it. In September, 2002, we wrote to the
         board of directors making suggestions about governance, profitability,
         and financial public relations. We continue to address these topics
         with members of the board, with management, and with other shareholders
         of the company. We believe that recent concerns about reimbursement
         rates have driven the share price to an extremely undervalued level.

Item 5.  Interest in Securities of the Issuer

         (a,b)  D3 owns and has sole voting power over 820,000 AMED shares.

         (c)    D3's transactions in the last 60 days:
                     Date        # of shares    Price paid
                   --------      -----------    ----------
                   10/21/02         79,000        $5.92
                   10/22            13,000         5.83

         (d)    N/A

         (e)    N/A

Item 6.  Contracts, Arrangements, Understandings or Relationships with Respect
         to Securities of the Issuer

         N/A

Item 7.  Material to be Filed as Exhibits

         N/A

Signature

     After reasonable inquiry and to the best of my knowledge and belief, I
certify that the information set forth in this statement is true, complete and
correct.



October 22, 2002                            /s/DAVID NIERENBERG
-----------------                           ------------------------------------
      Date                                  David Nierenberg
                                            President
                                            Nierenberg Investment Management
                                              Company, Inc., the General Partner
                                              of The D3 Family Fund, L.P.

                                                                   Page 11 of 17

Item 1.  Security and Issuer

         Common stock of Amedisys, Inc. (AMED),
         11100 Mead Road, Suite 300,
         Baton Rouge, LA 70816

Item 2.  Identity and Background

         (a)  Haredale Ltd., a Bahamian corporation.

         (b)  P.O. Box N-4465, Nassau, New Providence, The Bahamas.

         (c)  Haredale is in the investment business at the address above.

         (d)  None

         (e)  None

         (f)  The Bahamas.

Item 3.  Source and Amount of Funds or Other Consideration

         Haredale owns, and Mr. Nierenberg has sole voting and dispositive
         power over, its 24,500 shares.

Item 4.  Purpose of Transaction

         See Item 4., page 10.

Item 5.  Interest in Securities of the Issuer

         (a,b)  Haredale owns, and Mr. Nierenberg has sole voting and
                dispositive power over, its 24,500 shares.

         (c)    N/A

         (d)    N/A

         (e)    N/A

Item 6.  Contracts, Arrangements, Understandings or Relationships with Respect
         to Securities of the Issuer

         Haredale pays Mr. Nierenberg an annual management fee and a share
         of its net profits for his personal management of its account.

Item 7.  Material to be Filed as Exhibits

         N/A

Signature

     After reasonable inquiry and to the best of my knowledge and belief, I
certify that the information set forth in this statement is true, complete
and correct.



October 22, 2002                            /s/DAVID NIERENBERG
------------------                          ------------------------------------
      Date                                  David Nierenberg
                                            Authorized to trade for
                                              Haredale, Ltd.

                                                                   Page 12 of 17

Item 1.  Security and Issuer

         Common stock of Amedisys, Inc. (AMED),
         11100 Mead Road, Suite 300,
         Baton Rouge, LA 70816

Item 2.  Identity and Background

         (a)  Olivier Roux, a French citizen resident in the United Kingdom.

         (b)  Talisman Management Ltd., 37 Ixworth Place, London SW3, England.

         (c)  Mr. Roux is a management consultant.

         (d)  None

         (e)  None

         (f)  A French citizen resident in the United Kingdom.

Item 3.  Source and Amount of Funds or Other Consideration

         Mr. Roux owns, and Mr. Nierenberg has sole voting and dispositive power
         over, his 10,000 AMED shares.

Item 4.  Purpose of Transaction

         See Item 4., page 10.

Item 5.  Interest in Securities of the Issuer

         (a,b)  Mr. Roux owns, and Mr. Nierenberg has sole voting and
                dispositive power over, his 10,000 AMED shares.

         (c)    N/A

         (d)    N/A

         (e)    N/A

Item 6.  Contracts, Arrangements, Understandings or Relationships with Respect
         to Securities of the Issuer

         Mr. Roux pays Mr. Nierenberg an annual management fee and a share of
         its net profits for his personal management of Mr. Roux's account.

Item 7.  Material to be Filed as Exhibits

         N/A

Signature

     After reasonable inquiry and to the best of my knowledge and belief, I
certify that the information set forth in this statement is true, complete and
correct.



October 22, 2002                            /s/DAVID NIERENBERG
------------------                          ------------------------------------
      Date                                  David Nierenberg
                                            Authorized to trade for
                                              Olivier Roux

                                                                   Page 13 of 17

Item 1.  Security and Issuer

         Common stock of Amedisys, Inc. (AMED),
         11100 Mead Road, Suite 300,
         Baton Rouge, LA 70816

Item 2.  Identity and Background

         (a)  James Henry Hildebrandt a Canadian citizen resident in Hong Kong.

         (b)  c/o Bain & Company, Tenth Floor, One Pacific Place, 88 Queensway,
              Hong Kong.

         (c)  Mr. Hildebrandt is a management consultant.

         (d)  None

         (e)  None

         (f)  A Canadian citizen resident in Hong Kong.

Item 3.  Source and Amount of Funds or Other Consideration

         Mr. Hildebrandt owns, and Mr. Nierenberg has sole voting and
         dispositive power over, his 7,000 AMED shares.

Item 4.  Purpose of Transaction

         See Item 4., page 10.

Item 5.  Interest in Securities of the Issuer

         (a,b)  Mr. Hildebrandt owns, and Mr. Nierenberg has sole voting and
                dispositive power over, his 7,000 AMED shares.

         (c)    N/A

         (d)    N/A

         (e)    N/A

Item 6.  Contracts, Arrangements, Understandings or Relationships with Respect
         to Securities of the Issuer

         Mr. Hildebrandt pays Mr. Nierenberg an annual management fee and a
         share of its net profits for his personal management of his account.

Item 7.  Material to be Filed as Exhibits

         N/A

Signature

     After reasonable inquiry and to the best of my knowledge and belief, I
certify that the information set forth in this statement is true, complete and
correct.



October 22, 2002                            /s/DAVID NIERENBERG
------------------                          ------------------------------------
      Date                                  David Nierenberg
                                            Authorized to trade for
                                              John Henry Hildebrandt

                                                                   Page 14 of 17

Item 1.  Security and Issuer

         Common stock of Amedisys, Inc. (AMED),
         11100 Mead Road, Suite 300,
         Baton Rouge, LA 70816

Item 2.  Identity and Background

         (a)  Toxford Corporation, a Channel Islands corporation.

         (b)  P.O. Box 3048, St. Andrews House, Le Bordage, St. Peter Port,
              Guernsey, Channel Islands, British Isles.

         (c)  Toxford Corporation is in the investment business.

         (d)  None

         (e)  None

         (f)  Channel Islands, British Isles.

Item 3.  Source and Amount of Funds or Other Consideration

         Toxford Corporation owns, and Mr. Nierenberg has sole voting and
         dispositive power over, its 4,000 AMED shares.

Item 4.  Purpose of Transaction

         See Item 4., page 10.

Item 5.  Interest in Securities of the Issuer

         (a,b)  Toxford Corporation owns, and Mr. Nierenberg has sole voting and
                dispositive power over, its 4,000 AMED shares.

         (c)    N/A

         (d)    N/A

         (e)    N/A

Item 6.  Contracts, Arrangements, Understandings or Relationships with Respect
         to Securities of the Issuer

         Toxford Corporation pays Mr. Nierenberg an annual management fee and a
         share of its net profits for his personal management of its account.

Item 7.  Material to be Filed as Exhibits

         N/A

Signature

     After reasonable inquiry and to the best of my knowledge and belief, I
certify that the information set forth in this statement is true, complete and
correct.



October 22, 2002                            /s/DAVID NIERENBERG
------------------                          ------------------------------------
      Date                                  David Nierenberg
                                            Authorized to trade for
                                              Toxford Corporation


                                                                   Page 15 of 17

Item 1.  Security and Issuer

         Common stock of Amedisys, Inc. (AMED),
         11100 Mead Road, Suite 300,
         Baton Rouge, LA 70816

Item 2.  Identity and Background

         (a)  Henry Hooper, a United States Citizen.

         (b)  2900 SE 149th Court, Vancouver, WA 98783.

         (c)  Mr. Hooper is a General Partner of the D3 Family Fund, LP.

         (d)  No convictions or administrative proceedings as described in Items
              2(d) and (e).

         (e)  None.

         (f)  United States, resident of Washington State.

Item 3.  Source and Amount of Funds or Other Consideration

         Mr. Hooper has sole voting and dispositive power over, his 1,500 AMED
         shares.

Item 4.  Purpose of Transaction

         See Item 4., page 10.

Item 5.  Interest in Securities of the Issuer

         (a,b)  Mr. Hooper has sole voting and dispositive power over, his
                1,500 AMED shares.

         (c)    N/A

         (d)    N/A

         (e)    N/A

Item 6.  Contracts, Arrangements, Understandings or Relationships with Respect
         to Securities of the Issuer

         N/A

Item 7.  Material to be Filed as Exhibits

         N/A

Signature

     After reasonable inquiry and to the best of my knowledge and belief, I
certify that the information set forth in this statement is true, complete and
correct.



October 22, 2002                            /s/DAVID NIERENBERG
-----------------                           ------------------------------------
      Date                                  David Nierenberg
                                            President
                                            Nierenberg Investment Management
                                              Company, Inc., the General Partner
                                              of The D3 Family Fund, L.P.

                                                                   Page 16 of 17

Item 1.  Security and Issuer

         Common stock of Amedisys, Inc. (AMED),
         11100 Mead Road, Suite 300,
         Baton Rouge, LA 70816

Item 2.  Identity and Background

         (a)  Florence Cies, an American Citizen.

         (b)  3300 Narvaez, #26, San Jose, California  95136

         (c)  Cies is retired.

         (d)  None

         (e)  None

         (f)  American

Item 3.  Source and Amount of Funds or Other Consideration

         Cies owns, and Mr. Nierenberg has sole voting and
         dispositive power over, her 10,000 AMED shares.

Item 4.  Purpose of Transaction

         See Item 4., page 10.

Item 5.  Interest in Securities of the Issuer

         (a,b)  Cies owns, and Mr. Nierenberg has sole voting and
                dispositive power over, her 10,000 AMED shares.

         (c)    Transactions in the last 60 days:
                     Date        # of shares    Price paid
                   --------      -----------    ----------
                    8/13/02         10,000        $7.20

         (d)    N/A

         (e)    N/A

Item 6.  Contracts, Arrangements, Understandings or Relationships with Respect
         to Securities of the Issuer

         N/A

Item 7.  Material to be Filed as Exhibits

         N/A

Signature

     After reasonable inquiry and to the best of my knowledge and belief, I
certify that the information set forth in this statement is true, complete and
correct.



October 22, 2002                            /s/DAVID NIERENBERG
------------------                          ------------------------------------
      Date                                  David Nierenberg
                                            Authorized to trade for
                                              Florence Cies



                                                                   Page 17 of 17

Item 1.  Security and Issuer

         Common stock of Amedisys, Inc. (AMED),
         11100 Mead Road, Suite 300,
         Baton Rouge, LA 70816

Item 2.  Identity and Background

         (a)  The David and Patricia Nierenberg 1993 Irrevocable Trust, Lawrence
              K. Orr, Trustee, June 11, 1993

         (b)  Lawrence K. Orr, Trinity Ventures, 3000 Sand Hill Rd., Bldg. 4,
              Suite 160, Menlo Park, CA 94025.

         (c)  This is an irrevocable trust for the benefit of the Nierenberg
              children.

         (d)  None

         (e)  None

         (f)  A California trust.

Item 3.  Source and Amount of Funds or Other Consideration

         Mr. Orr has sole voting and dispositive power over the trust's 11,000
         AMED shares.

Item 4.  Purpose of Transaction

         See Item 4., page 10.

Item 5.  Interest in Securities of the Issuer

         (a,b)  Mr. Orr has sole voting and dispositive power over the trust's
         11,000 AMED shares.

         (c)    Transactions in the last 60 days:
                     Date        # of shares    Price paid
                   --------      -----------    ----------
                    8/13/02         10,000        $7.02

         (d)    N/A

         (e)    N/A

Item 6.  Contracts, Arrangements, Understandings or Relationships with Respect
         to Securities of the Issuer

         N/A

Item 7.  Material to be Filed as Exhibits

         N/A

Signature

     After reasonable inquiry and to the best of my knowledge and belief, I
certify that the information set forth in this statement is true, complete and
correct.



October 22, 2002                            /s/DAVID NIERENBERG
------------------                          ------------------------------------
      Date                                  David Nierenberg
                                            Authorized to trade for
                                            The Nierenberg Family 1993 Trust